GABRG2 rs2542052: Understanding Epilepsy-Related Genetic Variants
The rs2542052 variant is located within the GABRG2 gene, which provides instructions for creating a critical component of the brain's inhibitory signaling system. Research associates variations in this gene with a spectrum of epilepsy syndromes, ranging from febrile seizures to more complex genetic epilepsy conditions.
What each genotype means
Increased epilepsy risk profile
This genotype is associated with an increased risk for a spectrum of epilepsy syndromes, including genetic epilepsy with febrile seizures plus (GEFS+). Because GABRG2 mutations exhibit incomplete penetrance, carrying this genotype does not guarantee the development of seizures. Please discuss any concerns regarding seizure history or neurological health with a qualified clinician.
The frequency of this specific genotype varies significantly by ancestry and is generally considered rare in the general population.
Potential epilepsy risk carrier
Individuals with this genotype carry one copy of the variant associated with altered GABAA receptor function, which has been linked to febrile seizures and various epilepsy syndromes. The clinical expression of this genotype is highly variable, and many carriers may remain asymptomatic throughout their lives. Consult with a neurologist if you have a personal or family history of seizures.
This heterozygous genotype is found at low frequencies across most global populations, with prevalence rates differing by ethnic background.
Typical risk profile
This is the common, ancestral genotype for this position in the GABRG2 gene. It is not associated with the increased risk of epilepsy syndromes linked to the variant allele. No specific clinical action is indicated based on this genotype.
This is the most common genotype observed in the vast majority of individuals across all major ancestral groups.
What is the rs2542052 Variant?
The rs2542052 variant is a specific single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The GABRG2 gene is located on chromosome 5 and encodes the gamma-2 subunit of the GABA-A receptor. This receptor is a ligand-gated ion channel that plays a fundamental role in the central nervous system by mediating inhibitory neurotransmission. When these receptors function correctly, they help regulate the excitability of neurons, effectively acting as a 'brake' on brain activity. Variations in the DNA sequence of this gene can potentially alter the structure or expression of the gamma-2 subunit, which may influence how these receptors assemble or function at the neuronal surface. Scientists study these specific locations to understand how minor changes in the genetic code can contribute to the underlying biological mechanisms of neurological conditions.
The Role of GABRG2 in Brain Function
The GABRG2 gene is essential for the proper formation and trafficking of GABA-A receptors. These receptors are the primary mediators of fast inhibitory synaptic transmission in the human brain. By allowing chloride ions to flow into neurons, the GABA-A receptor reduces the likelihood that a neuron will fire an electrical signal, thereby maintaining a balance between excitation and inhibition. The gamma-2 subunit, encoded by GABRG2, is particularly important because it confers specific properties to the receptor, including sensitivity to benzodiazepines and the formation of high-conductance channels. When the GABRG2 gene is affected by pathogenic variants, the resulting GABA-A receptors may show reduced cell surface expression or altered channel kinetics. Such functional deficits can disrupt the delicate balance of neuronal signaling, potentially lowering the threshold for seizure activity. Understanding this gene's role is a cornerstone of modern epilepsy research, as it highlights how molecular defects in synaptic machinery can manifest as clinical seizure disorders.
Research Associations and Evidence
The GABRG2 gene is widely recognized in clinical literature as an 'epilepsy gene.' Research has established that variants in this gene are associated with a broad spectrum of clinical phenotypes, including simple febrile seizures (FS), childhood absence epilepsy (CAE), and genetic epilepsy with febrile seizures plus (GEFS+). In more severe cases, certain GABRG2 variants have been linked to epileptic encephalopathies, such as Dravet syndrome. The evidence for the gene's involvement in these conditions is considered strong, supported by functional studies using patch-clamp recording and immunoblotting to demonstrate how specific mutations impair receptor biogenesis. While many studies focus on rare, de novo mutations, common variants like rs2542052 are investigated for their potential contribution to susceptibility. It is important to note that the presence of a variant does not guarantee the development of a specific condition, as epilepsy is often a complex, polygenic trait influenced by both genetic and environmental factors.
Population Frequency and Ancestry
The frequency of the rs2542052 variant varies significantly across different global populations and ancestral backgrounds. Genetic databases such as gnomAD provide data on how often specific alleles appear in diverse cohorts, showing that the prevalence of this SNP is not uniform. Because epilepsy syndromes associated with GABRG2 can exhibit incomplete penetrance—meaning an individual may carry a variant without manifesting clinical symptoms—the relationship between population frequency and disease prevalence is complex. Researchers often look at these frequency differences to determine if certain populations might have a higher genetic predisposition to specific seizure types. However, because this variant is just one of many potential contributors to epilepsy, its presence in a population does not necessarily correlate directly with the incidence of epilepsy in that group. Clinicians and researchers continue to study these variations to better understand the global landscape of genetic risk factors for neurological disorders.
Interpreting Genetic Information
Accessing information about your genetic variants can be informative, but it is essential to interpret these findings within a clinical context. A variant like rs2542052 is a piece of data that researchers use to study disease mechanisms, but it is not a diagnostic tool for individuals. Epilepsy is a complex condition, and the clinical significance of any single variant depends on a person's entire genetic profile, family history, and environmental factors. If you have concerns about epilepsy or seizure disorders, it is vital to consult with a neurologist or a genetic counselor who can provide a professional evaluation. They can help determine if genetic testing is appropriate and explain what the results mean for your specific health situation. Never use genetic data to make medical decisions or change medications without direct supervision from your healthcare provider, as they are the only ones qualified to interpret these findings in the context of your overall health.
How common is this variant?
The frequency of the rs2542052 variant varies by ancestry, with different populations showing distinct distributions of the A and G alleles.
Frequently asked questions
Is rs2542052 a cause of epilepsy?
The rs2542052 variant is associated with susceptibility to various epilepsy syndromes, but it is not considered a direct, singular cause of epilepsy. Epilepsy is a complex condition influenced by many genetic and environmental factors.
Should I get tested for GABRG2 variants?
Genetic testing for epilepsy is typically reserved for individuals with specific clinical presentations and is ordered by a neurologist. You should discuss the necessity and implications of such testing with your healthcare provider.
Can I change my medication based on this variant?
No. You should never change your medication or treatment plan based on genetic information without consulting your clinician or pharmacist. They are responsible for managing your care based on your full clinical profile.
What is the difference between a variant and a mutation?
In modern genetics, the term 'variant' is used to describe any change in the DNA sequence, while 'mutation' is often reserved for variants that are known to cause disease. Many variants are benign and have no impact on health.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2542052?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.